During the corresponding time, Zimmer Biomet Holdings Inc recorded a revenue increase by 4.8 % year on year, sequentially revenue grew by 4.33 %. While revenue at the Zimmer Biomet Holdings Inc 's corporate clients
Zimmer Biomet Holdings Inc's Comment on Sales, Marketing and Customers
The company's primary customers include orthopedic surgeons, neurosurgeons, other specialists, healthcare institutions, stocking distributors, healthcare dealers, and healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent clinicians. Products are marketed and sold through two main channels: direct sales to healthcare institutions such as hospitals and ambulatory surgery centers, and through stocking distributors and healthcare dealers. Consignment sales accounted for approximately 85 percent of net sales in 2025, with no individual customer representing more than 2 percent of net sales. The company operates through three regional segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Americas segment, primarily the U.S., is the largest, with the U.S. accounting for about 95 percent of net sales in this region in 2025. The U.S. sales force includes employees and independent sales agents, with a recent initiative to convert many independent agents to employees. Customers and markets named across filings include Zimmer Biomet.
Zimmer Biomet Holdings Inc’s Comment on Sales, Marketing and Customers
The company's primary customers include orthopedic surgeons, neurosurgeons, other specialists, healthcare institutions, stocking distributors, healthcare dealers, and healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent clinicians. Products are marketed and sold through two main channels: direct sales to healthcare institutions such as hospitals and ambulatory surgery centers, and through stocking distributors and healthcare dealers. Consignment sales accounted for approximately 85 percent of net sales in 2025, with no individual customer representing more than 2 percent of net sales. The company operates through three regional segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Americas segment, primarily the U.S., is the largest, with the U.S. accounting for about 95 percent of net sales in this region in 2025. The U.S. sales force includes employees and independent sales agents, with a recent initiative to convert many independent agents to employees. Customers and markets named across filings include Zimmer Biomet.
Sources:
Zimmer Biomet Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Zimmer Biomet Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Zimmer Biomet Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
112.51 %